Vascular Biogenics Ltd.

NasdaqCM:VBLT Stok Raporu

Piyasa değeri: US$12.1m

Vascular Biogenics Yönetim

Yönetim kriter kontrolleri 4/4

Vascular Biogenics CEO'su Dror Harats, Jan2001 tarihinde atandı, in görev süresi 22.75 yıldır. in toplam yıllık tazminatı $ 887.62K olup, şirket hissesi ve opsiyonları dahil olmak üzere 40.3% maaş ve 59.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.47% ine doğrudan sahiptir ve bu hisseler $ 177.68K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 17.8 yıl ve 5.4 yıldır.

Anahtar bilgiler

Dror Harats

İcra Kurulu Başkanı

US$887.6k

Toplam tazminat

CEO maaş yüzdesi40.3%
CEO görev süresi22.8yrs
CEO sahipliği1.5%
Yönetim ortalama görev süresi17.8yrs
Yönetim Kurulu ortalama görev süresi5.4yrs

Son yönetim güncellemeleri

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Recent updates

VBL Therapeutics receives non-compliance letter from Nasdaq

Sep 01

VBL Therapeutics GAAP EPS of -$0.12

Aug 15

VBL Therapeutics' late-stage trial for ovarian cancer treatment does not meet main goals

Jul 19

Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

May 18
Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation

Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump

Sep 03

How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

Mar 17
How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?

How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

Jan 28
How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?

VBL Therapeutics expands the ovarian cancer trial in Europe

Dec 29

Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Dec 24
Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?

Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 19
Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates

VBL Therapeutics EPS beats by $0.01, misses on revenue

Nov 16

CEO Tazminat Analizi

Dror Harats'un ücretlendirmesi Vascular Biogenics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$25m

Dec 31 2022US$888kUS$357k

-US$32m

Sep 30 2022n/an/a

-US$38m

Jun 30 2022n/an/a

-US$35m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$1mUS$349k

-US$30m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$27m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020n/an/a

-US$24m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$889kUS$405k

-US$19m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$17m

Dec 31 2018US$815kUS$375k

-US$20m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$12m

Dec 31 2017n/an/a

-US$10m

Sep 30 2017n/an/a

-US$21m

Jun 30 2017n/an/a

-US$18m

Mar 31 2017n/an/a

-US$16m

Dec 31 2016US$515kUS$406k

-US$16m

Tazminat ve Piyasa: Dror 'ın toplam tazminatı ($USD 887.62K ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 647.72K ).

Tazminat ve Kazançlar: Dror 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Dror Harats (66 yo)

22.8yrs

Görev süresi

US$887,624

Tazminat

Prof. Dror Harats, MD, has been the Chief Executive Officer of Vascular Biogenics Ltd., since January 2001. Prof. Harats founded VBL in 2000 based on many years of research in Atherosclerosis, Vascular Bio...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Dror Harats
CEO & Director22.8yrsUS$887.62k1.47%
$ 177.7k
Samuel Backenroth
Chief Financial Officer2yrsUS$669.08k0.68%
$ 81.9k
Eyal Breitbart
Senior Vice President of Research & Operations17.8yrsUS$433.79kVeri yok
Ayelet Horn
General Counsel23.8yrsVeri yokVeri yok
Erez Feige
Senior Vice President of Business Operations1.7yrsUS$374.71kVeri yok

17.8yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: VBLT 'un yönetim ekibi deneyimli ve deneyimlidir ( 17.8 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Dror Harats
CEO & Director22.8yrsUS$887.62k1.47%
$ 177.7k
Ruth Alon
Independent Non-Executive Director13.6yrsUS$94.25k0%
$ 0
David Hastings
Independent Non-Executive Director5.8yrsUS$101.30k0%
$ 0
Ruth Arnon
Scientific Consultant & Member of Scientific Advisory Board2.3yrsVeri yokVeri yok
Marc Kozin
Independent Non-Executive Chairman3yrsUS$205.67k0.050%
$ 6.1k
Shmuel Ben-Zvi
Independent Non-Executive Director5.1yrsUS$96.88k0.077%
$ 9.4k
Patrick Wen
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Andrew Brenner
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Richard Penson
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Timothy Cloughesy
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Nicholas Butowski
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Kathleen Moore
Member of Scientific Advisory Boardno dataVeri yokVeri yok

5.4yrs

Ortalama Görev Süresi

64.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: VBLT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.4 yıldır).